JMP Securities Downgrades agilon health (AGL)
Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market Outperform to Market Perform. Analyst Price Forecast Suggests 208.39% Upside As of October 22,
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Financial writer downgrades agilon health, inc. to “sell” due to poor performance and uncertain future, impacting investor confidence. Click for this AGL update.
agilon health, inc. (NYSE:AGL) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 10, 2024 Operator: Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call. My name is Kate and I will be the moderator for today’s call.
Agilon Health Inc (AGL) Stock Settles at $1.84: What’s Contributing to This Price Point?
On Friday, Agilon Health Inc (AGL) stock saw a decline, ending the day at $1.84 which represents a decrease of $-0.95 or -34.05% from the prior close of $2.79. The stock opened at $1.86 and touched a low of $1.8 during the day, reaching a high of $2.02. The volume of shares traded was 19.07 million exceeding the average volume of 4.25 million.
agilon health (AGL) to Release Earnings on Thursday
(NYSE:AGL – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Thursday, November 7th. Analysts expect agilon health to post earnings of ($0.10) per share for the quarter.
Agilon Health Inc (AGL) Q3 2024 Earnings Report Preview: What To Look For
Agilon Health Inc (NYSE:AGL) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $1,470.71 million, and the earnings are expected to come in at -$0.11 per share.
Agilon Health downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Constantine Davides downgraded Agilon Health (AGL) to Market Perform from Outperform without a price target following
Business Insider1d
Agilon Health: Hold Rating Amid Financial Challenges and Strategic Adjustments
Whit Mayo, an analyst from Leerink Partners, reiterated the Hold rating on Agilon Health (AGL – Research Report). The associated price target is $2.50. Whit Mayo has given his Hold rating due to a ...
agilon health, inc. (NYSE:AGL) Receives Average Recommendation of “Hold” from Analysts
(NYSE:AGL – Get Free Report) has been given an average recommendation of “Hold” by the twenty-one ratings firms that are ...
agilon cut to market perform by William Blair on Q3 earnings report
William Blair lowered its rating of agilon health (AGL) to market perform, citing the company’s Q3 adjusted EBITDA miss. Read ...
Agilon Health price target lowered to $2 from $7 at Stifel
Stifel lowered the firm’s price target on Agilon Health (AGL) to $2 from $7 and keeps a Hold rating on the shares. Agilon has traded down ...
MarketWatch5d
Agilon Health Shares Dive 31% on Plans to Exit Contracts, Wider 3Q Loss
Shares of Agilon Health fell sharply after the company said it would exit some payor contracts and partnerships and posted a wider-than-expected loss in the third quarter. The stock was down 31% ...
Modern Healthcare2d
ACO REACH savings report invigorates calls for extension
ACO REACH saved Medicare money in 2023 but the Centers for Medicare and Medicaid Services hasn't committed to sustaining it ...
Agilon Health cuts FY24 adjusted EBITDA to ($155M)-($135M) from ($60M)-($15)
EST Agilon Health (AGL) cuts FY24 adjusted EBITDA to (155M)-(135M) from (60M)-(15) Published first on TheFly – the ultimate source ...